LIVN (STOCKS)
LivaNova PLC Ordinary Shares
$64.580000
+1.800000 (+2.87%)
Prev close: $62.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vladimir A. Makatsaria
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,532.97M
- Employees
- 2,900
- P/E (TTM)
- -14.43
- P/B (TTM)
- 2.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.86 | $0.83 | +0.0286 | +3.44% |
|
Sep 2025 (Q3)
|
$1.11 | $0.94 | +0.1726 | +18.41% |
|
Jun 2025 (Q2)
|
$1.05 | $0.87 | +0.1773 | +20.32% |
|
Mar 2025 (Q1)
|
$0.88 | $0.78 | +0.1023 | +13.15% |
Financial Statements
| Revenues | $1.39B |
| Benefits Costs and Expenses | $1.61B |
| Cost Of Revenue | $448.18M |
| Costs And Expenses | $1.61B |
| Gross Profit | $939.87M |
| Nonoperating Income/Loss | -$2.68M |
| Operating Expenses | $740.48M |
| Selling, General, and Administrative Expenses | $548.81M |
| Research and Development | $185.76M |
| Other Operating Expenses | $5.90M |
| Operating Income/Loss | $199.39M |
| Income/Loss Before Equity Method Investments | -$220.78M |
| Income/Loss From Continuing Operations After Tax | -$242.42M |
| Income/Loss From Continuing Operations Before Tax | -$220.78M |
| Income/Loss From Equity Method Investments | -$51.00K |
| Income Tax Expense/Benefit | $21.64M |
| Income Tax Expense/Benefit, Current | $21.18M |
| Income Tax Expense/Benefit, Deferred | $455.00K |
| Net Income/Loss | -$242.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$242.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$242.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.45 |
| Diluted Earnings Per Share | -$4.45 |
| Basic Average Shares | 54,548,000 |
| Diluted Average Shares | 54,548,000 |
| Assets | $2.61B |
| Current Assets | $1.10B |
| Inventory | $164.70M |
| Other Current Assets | $936.91M |
| Noncurrent Assets | $1.50B |
| Fixed Assets | $242.60M |
| Intangible Assets | $229.96M |
| Other Non-current Assets | $1.03B |
| Liabilities | $1.41B |
| Current Liabilities | $808.07M |
| Accounts Payable | $97.16M |
| Other Current Liabilities | $710.92M |
| Noncurrent Liabilities | $597.99M |
| Long-term Debt | $376.10M |
| Other Non-current Liabilities | $221.89M |
| Equity | $1.20B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.20B |
| Liabilities And Equity | $2.61B |
| Net Cash Flow From Operating Activities | $254.34M |
| Net Cash Flow From Operating Activities, Continuing | $254.34M |
| Net Cash Flow From Investing Activities | -$72.91M |
| Net Cash Flow From Investing Activities, Continuing | -$72.91M |
| Net Cash Flow From Financing Activities | -$285.66M |
| Net Cash Flow From Financing Activities, Continuing | -$285.66M |
| Exchange Gains/Losses | $16.23M |
| Net Cash Flow | -$88.00M |
| Net Cash Flow, Continuing | -$104.23M |
| Comprehensive Income/Loss | -$154.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$154.97M |
| Other Comprehensive Income/Loss | -$154.97M |
| Other Comprehensive Income/Loss Attributable To Parent | $87.50M |